Drug Delivery Business
WEBSep 6, 2023 · CorFlow Therapeutics announced today that it raised €44 million ($48.5 million) to support its novel diagnostic and drug delivery platform. Broadview Ventures and Panakes Partners led the financing round. 415 Capital, Merieux Equity Partners, Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners, M&L Investments, Unorthodox Ventures, KOFA Healthcare and Monte Carlo Capital ...
Kindeva wins £33M grant to enhance drug-delivering inhalers
WEBAugust 4, 2023 By Sean Whooley. Kindeva Drug Delivery announced that it received a grant from a UK fund worth a $42.2 million (£33 million) investment. The grant from the UK Government’s Life Sciences Innovation Manufacturing Fund (LSIMF) aims to help Kindeva enhance inhaler manufacturing and sustainability. Funds improve Kindeva’s ...
Lilly partners with four companies on insulin pen tech
WEBMay 6, 2021 By Nancy Crotti. Eli Lilly (NYSE:LLY) today announced deals with four companies whose diabetes management tech will work with Lilly’s latest insulin pen. The Tempo Pen is a modified version of Lilly’s existing prefilled, disposable insulin pen to which the Tempo Smart Button — in late-stage development – attaches. Through ...
The company behind Narcan looks toward a treatment for fentanyl ...
WEBMar 13, 2018 · A nasal spray designed to reverse opioid overdoses called Narcan has become a life-saving tool used by police departments and communities around the country. Now, the company that created Narcan – Opiant Pharmaceuticals (NSDQ: OPNT) – is hoping that its latest drug-device combination can …
FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent
WEBMay 13, 2022 · Medtronic (NYSE:MDT) announced today that it received FDA approval for its Onyx Frontier drug-eluting stent (DES).. Onyx Frontier, the latest iteration of Medtronic’s Resolute DES family, was designed to leverage the same stent platform as Resolute with an enhanced delivery system for improving deliverability and increasing acute performance, even in the most challenging of cases.
Update: Insulet opens manufacturing facility in Acton, Mass.
WEBFebruary 16, 2017 By Sarah Faulkner. Insulet (NSDQ: PODD) said yesterday that it acquired a manufacturing facility in Acton, Mass. The Billerica, Mass.-based company said that its new facility will allow Insulet to more efficiently manufacture its OmniPod system compared to 4 of the company’s manufacturing lines at its contract manufacturer ...
Insulet data shows Omnipod 5's superiority to regular pump therapy
WEBMar 8, 2024 · Results demonstrated significantly lower mean glucose and time above 180 mg/dL in the Omnipod 5 group. That group also spent significantly less time below 70 mg/dL. Mean time decreased from 1.66% to 1.18% with Omnipod 5, compared to an increase from 1.66% to 1.75% in the control group. Time below 54 mg/dL proved non-inferior between groups.
SiBionics wins CE mark for 14-day CGM - Drug Delivery Business
WEBOct 31, 2023 · SiBionics announced today that it received CE mark approval in Europe for its GS1 continuous glucose monitoring (CGM) system. The company designed its CGM system to provide healthcare providers and patients with data necessary for maintaining glucose control. It offers 14 days of calibration-free …
Insulin pens: Meet the insulin-makers and device companies
WEBMar 19, 2018 · Diamesco. This Koreo-based company has developed Pendiq, a digital insulin pen that can store a user’s last 1000 injections with the associated date, time and dose. The Bluetooth-enabled system is capable of dosing down to 0.1-unit amounts and delivers insulin using a motor-driven injection. Diamesco ‘s device has …
Stevanato Group is constructing a new facility in Indiana
WEBOct 4, 2021 · Stevanato Group (NYSE:STVN) announced today that it will begin construction on a new U.S. facility in Fishers, Indiana. Piombino Dese, Italy-based Stevanato Group will begin construction on the new facility this month with expectations for the site to be operational in 2023. According to a …